{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:21:48Z","timestamp":1782602508497,"version":"3.54.5"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100013213","name":"ARUP Institute for Clinical and Experimental Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013213","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>INTRODUCTION<\/jats:title><jats:p>Parathyroid hormone\u2013related peptide (PTHrP) is involved in activating pathways, allowing tumor cells to form bone metastases. Measurement of PTHrP is used for the diagnosis and clinical management of patients suspected of hypercalcemia of malignancy. We developed an LC-MS\/MS method for measuring PTHrP, established sex-specific reference intervals, and assessed the method's performance.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>PTHrP was enriched from plasma samples with rabbit polyclonal anti-PTHrP antibody conjugated to magnetic beads. Enriched PTHrP was digested with trypsin, and PTHrP-specific tryptic peptide was analyzed with 2-dimensional LC-MS\/MS in multiple reaction monitoring mode.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The lower limit of quantification was 0.6 pmol\/L, and the upper limit of linearity was 600 pmol\/L. Total imprecision was &amp;lt;10%. Very poor agreement was observed with the RIA (n = 207; Deming regression RIA = 0.059 \u00d7 LC-MS\/MS \u2212 1.8, r = 0.483; Sy|x = 3.9). Evaluation of the clinical performance of the assay using samples from patients with and without hypercalcemia (n = 199) resulted in an area under the ROC curve of 0.874. In sets of consecutively analyzed routine samples of patients assessed for hypercalcemia, the PTHrP positivity rate by RIA (n = 1376) was 1.9%, and 26.6% by LC-MS\/MS (n = 1705). Concentrations were below the lower limit of quantification in 95.6% of the samples by RIA and 2.0% by LC-MS\/MS.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>PTHrP is a normal constituent in circulating blood and its concentrations are substantially underestimated by commercial RIAs, causing false-negative results in samples from patients suspected of hypercalcemia. Our observations suggest a link between increased concentrations of PTHrP in postmenopausal women with low body mass index and increased incidence of osteoporosis.<\/jats:p><\/jats:sec>","DOI":"10.1373\/clinchem.2015.244012","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T03:18:47Z","timestamp":1447816727000},"page":"218-226","source":"Crossref","is-referenced-by-count":25,"title":["LC-MS\/MS Measurement of Parathyroid Hormone\u2013Related Peptide"],"prefix":"10.1093","volume":"62","author":[{"given":"Mark M","family":"Kushnir","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"},{"name":"Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L","family":"Rockwood","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"},{"name":"Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick G","family":"Strathmann","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"},{"name":"Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L","family":"Frank","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"},{"name":"Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joely A","family":"Straseski","sequence":"first","affiliation":[{"name":"ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT"},{"name":"Department of Pathology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Wayne","family":"Meikle","sequence":"first","affiliation":[{"name":"Department of Pathology and"},{"name":"Department of Medicine, University of Utah, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"2020022605332297900_B1","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1073\/pnas.84.14.5048","article-title":"Parathyroid hormone-related protein purified from a human lung cancer cell line","volume":"84","author":"Moseley","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020022605332297900_B2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/0006-291X(87)90581-X","article-title":"N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains","volume":"146","author":"Stewart","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"2020022605332297900_B3","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI113275","article-title":"Parathyroid hormonelike protein from human renal carcinoma cells: structural and functional homology with parathyroid hormone","volume":"80","author":"Strewler","year":"1987","journal-title":"J Clin Invest"},{"key":"2020022605332297900_B4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM198809013190906","article-title":"Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide","volume":"319","author":"Broadus","year":"1988","journal-title":"N Engl J Med"},{"key":"2020022605332297900_B5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1242\/dev.125.7.1285","article-title":"Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development","volume":"125","author":"Wysolmerski","year":"1998","journal-title":"Development"},{"key":"2020022605332297900_B6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"key":"2020022605332297900_B7","first-page":"665","article-title":"Receptors for PTH and PTHrP: their biological importance and functional properties","volume":"277","author":"Mannstadt","year":"1999","journal-title":"Am J Physiol"},{"key":"2020022605332297900_B8","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1210\/jc.2005-0675","article-title":"Clinical review: Rare causes of hypercalcemia","volume":"90","author":"Jacobs","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605332297900_B9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I","article-title":"Mechanisms of bone metastasis","volume":"80","author":"Mundy","year":"1997","journal-title":"Cancer"},{"key":"2020022605332297900_B10","first-page":"1322","article-title":"Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia\/lymphoma and B-cell lymphoma","volume":"79","author":"Ikeda","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020022605332297900_B11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/clinchem\/38.2.282","article-title":"Modified immunoradiometric assay of parathyroid hormone-related protein: clinical application in the differential diagnosis of hypercalcemia","volume":"38","author":"Pandian","year":"1992","journal-title":"Clin Chem"},{"key":"2020022605332297900_B12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-8981(98)00127-2","article-title":"Comparison of two immunoradiometric assays for parathyroid hormone-related protein in the evaluation of cancer patients with and without hypercalcemia","volume":"277","author":"de Miguel","year":"1998","journal-title":"Clin Chim Acta"},{"key":"2020022605332297900_B13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/clinchem\/39.3.414","article-title":"Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormone-related protein","volume":"39","author":"Fraser","year":"1993","journal-title":"Clin Chem"},{"key":"2020022605332297900_B14","first-page":"384","article-title":"Parathyroid-hormone-related peptide immunochemiluminometric assay developed with polyclonal antisera produced from a single animal","volume":"27","author":"Wu","year":"1997","journal-title":"Ann Clin Lab Sci"},{"key":"2020022605332297900_B15","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.1021\/ac020182a","article-title":"Mass spectrometric immunoassay for parathyroid hormone-related protein","volume":"74","author":"Lu","year":"2002","journal-title":"Anal Chem"},{"key":"2020022605332297900_B16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1055-9965.EPI-12-1318-T","article-title":"Identification of PTHrP(12\u201348) as a plasma biomarker associated with breast cancer bone metastasis","volume":"22","author":"Washam","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2020022605332297900_B17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.clinbiochem.2004.12.003","article-title":"Assessing analytical specificity in quantitative analysis using tandem mass spectrometry","volume":"38","author":"Kushnir","year":"2005","journal-title":"Clin Biochem"},{"key":"2020022605332297900_B18","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"key":"2020022605332297900_B19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1373\/clinchem.2012.195594","article-title":"Accurate measurement of thyroglobulin in serum in presence of anti-thyroglobulin autoantibodies","volume":"59","author":"Kushnir","year":"2013","journal-title":"Clin Chem"},{"key":"2020022605332297900_B20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/000456329403100106","article-title":"In vitro stability of endogenous parathyroid hormone-related protein in blood and plasma","volume":"31","author":"Hutchesson","year":"1994","journal-title":"Ann Clin Biochem"},{"key":"2020022605332297900_B21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1309\/AJCPFZYY7BBKK9JE","article-title":"Are samples in your freezer still good for biomarker discovery?","volume":"140","author":"Kushnir","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"2020022605332297900_B22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/obr.12244","article-title":"Complex association between body weight and fracture risk in postmenopausal women","volume":"16","author":"Mpalaris","year":"2015","journal-title":"Obes Rev"},{"key":"2020022605332297900_B23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-014-2899-7","article-title":"An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database","volume":"26","author":"Unni","year":"2015","journal-title":"Osteoporos Int"},{"key":"2020022605332297900_B24","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/clinchem\/46.10.1662","article-title":"Intraoperative parathyroid hormone analysis: a study of 200 consecutive cases","volume":"46","author":"Sokoll","year":"2000","journal-title":"Clin Chem"},{"key":"2020022605332297900_B25","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/bfm.2010.0101","article-title":"Changes in serum parathyroid hormone-related protein in breastfed preterm infants","volume":"7","author":"Tov","year":"2012","journal-title":"Breastfeed Med"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/1\/218\/32644224\/clinchem0218.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/62\/1\/218\/32644224\/clinchem0218.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:14:40Z","timestamp":1653567280000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/62\/1\/218\/5611753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,1]]},"published-print":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2015.244012","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,1,1]]},"published":{"date-parts":[[2016,1,1]]}}}